| Product Code: ETC7736719 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Drug Discovery Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Drug Discovery Market - Industry Life Cycle |
3.4 Japan Drug Discovery Market - Porter's Five Forces |
3.5 Japan Drug Discovery Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Japan Drug Discovery Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Japan Drug Discovery Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Japan Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing research and development investments in pharmaceutical industry in Japan |
4.2.2 Technological advancements in drug discovery processes |
4.2.3 Growing prevalence of chronic diseases in Japan |
4.3 Market Restraints |
4.3.1 Stringent regulations and lengthy approval processes for new drugs |
4.3.2 High cost associated with drug discovery and development in Japan |
5 Japan Drug Discovery Market Trends |
6 Japan Drug Discovery Market, By Types |
6.1 Japan Drug Discovery Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Drug Discovery Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Japan Drug Discovery Market Revenues & Volume, By Small Molecule Drugs, 2021- 2031F |
6.1.4 Japan Drug Discovery Market Revenues & Volume, By Biologic Drugs, 2021- 2031F |
6.2 Japan Drug Discovery Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Japan Drug Discovery Market Revenues & Volume, By High Throughput Screening, 2021- 2031F |
6.2.3 Japan Drug Discovery Market Revenues & Volume, By Pharmacogenomics, 2021- 2031F |
6.2.4 Japan Drug Discovery Market Revenues & Volume, By Combinatorial Chemistry, 2021- 2031F |
6.2.5 Japan Drug Discovery Market Revenues & Volume, By Nanotechnology, 2021- 2031F |
6.2.6 Japan Drug Discovery Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Japan Drug Discovery Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Japan Drug Discovery Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.3.3 Japan Drug Discovery Market Revenues & Volume, By Contract Research Organizations (CROs), 2021- 2031F |
6.3.4 Japan Drug Discovery Market Revenues & Volume, By Other, 2021- 2031F |
7 Japan Drug Discovery Market Import-Export Trade Statistics |
7.1 Japan Drug Discovery Market Export to Major Countries |
7.2 Japan Drug Discovery Market Imports from Major Countries |
8 Japan Drug Discovery Market Key Performance Indicators |
8.1 Number of new drug approvals by regulatory bodies in Japan |
8.2 Research and development expenditure in the pharmaceutical sector |
8.3 Number of patents filed for new drug discoveries |
8.4 Collaboration agreements between pharmaceutical companies and research institutions |
8.5 Rate of adoption of precision medicine techniques in drug discovery |
9 Japan Drug Discovery Market - Opportunity Assessment |
9.1 Japan Drug Discovery Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Japan Drug Discovery Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Japan Drug Discovery Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Japan Drug Discovery Market - Competitive Landscape |
10.1 Japan Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 Japan Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here